Cryofibrinogenemia
| Cryofibrinogenemia | |
|---|---|
| Classification and external resources | |
| OMIM | 123540 |
Cryofibrinogenemia is defined by the presence of circulating cold insoluble complexes of fibrin, fibrinogen, fibronectin, and fibrin split products with albumin, immunoglobulins and plasma proteins that precipitate from the patient's plasma in the cold.[1]:822
See also
References
Further reading
- Amdo, TD; Welker, JA (Mar 1, 2004). "An approach to the diagnosis and treatment of cryofibrinogenemia." (PDF). The American Journal of Medicine 116 (5): 332–7. doi:10.1016/j.amjmed.2003.09.033. PMID 14984819.
- Michaud, M; Pourrat, J (Apr 2013). "Cryofibrinogenemia.". Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 19 (3): 142–8. doi:10.1097/RHU.0b013e318289e06e. PMID 23519183.
- Kalbfleisch, John M.; Bird, Robert M. (3 November 1960). "Cryofibrinogenemia". New England Journal of Medicine 263 (18): 881–886. doi:10.1056/NEJM196011032631803.
- Begin, Philippe; Leclerc, Georgette (22 August 2013). "Familial Primary Cryofibrinogenemia". New England Journal of Medicine 369 (8): e10. doi:10.1056/NEJMicm1300987.
- van Geest, AJ; van Dooren-Greebe, RJ; Andriessen, MP; Blomjous, CE; Go, IH (Jan 1999). "Familial primary cryofibrinogenemia.". Journal of the European Academy of Dermatology and Venereology : JEADV 12 (1): 47–50. doi:10.1111/j.1468-3083.1999.tb00808.x. PMID 10188150.
- Soyfoo, MS; Goubella, A; Cogan, E; Wautrecht, JC; Ocmant, A; Stordeur, P (15 November 2011). "Clinical Significance of Cryofibrinogenemia: Possible Pathophysiological Link with Raynaud's Phenomenon". The Journal of Rheumatology 39 (1): 119–124. doi:10.3899/jrheum.110793.
This article is issued from Wikipedia - version of the Monday, March 07, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.